Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
38.34
+0.02 (+0.05%)
Streaming Delayed Price
Updated: 10:08 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Structure Therapeutics Inc. - American Depositary Shares
< Previous
1
2
3
4
Next >
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
July 13, 2023
An overweight world is hungry for new treatments. For now, two companies own the market.
Via
Investor's Business Daily
Why Shares of Structure Therapeutics Rose Monday
June 26, 2023
The company's lead diabetes and weight-loss therapy may benefit from a decision by Pfizer.
Via
The Motley Fool
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
June 26, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Cava Stock Makes A Stand In Mixed IPO Landscape: Where Does It Rank Against Other 2023 Wall Street Debuts?
June 16, 2023
In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterranean restaurant chain Cava Group (NYSE: CAVA) made a striking first public appearance on the New York...
Via
Benzinga
This Biotech Is Developing The Next Ozempic. Should You Buy It?
June 16, 2023
If it succeeds, it'll still face a battle for market share.
Via
The Motley Fool
Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years
June 12, 2023
If you can tolerate the risk and have some patience, both stocks could blossom.
Via
The Motley Fool
Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions
June 07, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics to Present at Jefferies Healthcare Conference
May 31, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
May 26, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
May 25, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference
May 18, 2023
Posters include data across biomarker, translation and clinical studies supporting development of cardiopulmonary programs LTSE-2578 and ANPA-0073
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 30, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race
February 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
There's a Lot to Love About Mineralys' Valentine's Day IPO
February 13, 2023
MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
February 07, 2023
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...
Via
Talk Markets
Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January
February 03, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.51% to 33,881.69 while the NASDAQ fell 1.32% to 12,039.79. The S&P 500 also fell, dropping, 0.98%...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.